Nanosyn, provider of Discovery on Demand services, is a medicinal chemistry and biological services contract research organization providing made-to-order focused compound libraries, hit-to-lead optimization, medicinal chemistry services and other innovative solutions to meet your drug discovery needs.
Our proprietary technology allows us to provide superior chemistry and biology services that effectively accelerate the drug discovery process for biotechnology and pharmaceutical companies worldwide. We use advanced microfluidics screening platform from Caliper LifeSciences to perform high-throughput screening and profiling.
October 2, 2019 - Nanosyn co-authored a paper in Haematologica identifying a PIKfyve kinase as a target in multiple myeloma. Read it here.
August 12, 2019 - Nanosyn co-authored a paper in Nature Research on how targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice. Read it here.
June 1, 2019 - Nanosyn acquired a 35,000 square foot facility of laboratory and manufacturing space in Hayward, CA. This is Nanosyn's third facility and brings the total square footage of Nanosyn's facilities to 100,000+ square feet.